In the weeks before the procedure, lab work will be performed to confirm that you have no underlying health issues and that you are a good candidate for the procedure
Tirzepatide, the first dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RA approved for both conditions, has paved the way for next-generation incretin-based therapies
The mechanisms are well-characterized and scientifically credible
Research shows that oocytes with higher levels of glutathione produce stronger, healthier embryos
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring, Md.) vol
Six weeks sits at the upper end of the commonly reported 4-6 week KLOW cycle